VitMode

Black Cohosh and Menopause Symptoms — What Does the Network Meta-Analysis Show?

Black cohosh (Actaea racemosa, also known as Cimicifuga racemosa) is one of the most popular herbal supplements for hot flashes and night sweats during menopause — marketed as a hormone-free alternative to hormone replacement therapy. A large network meta-analysis prepared for the UK's NICE menopause guideline did place it among the options more effective than placebo, but the picture is more nuanced than pharmacy packaging suggests.

AKdr Anna KowalczykAugust 27, 202611 min read
Table of contents

Hot flashes — a symptom that can genuinely disrupt daily life

Vasomotor symptoms of menopause — hot flashes and night sweats — are among the most recognizable, yet also most dismissed, aspects of the menopausal transition. As we describe more broadly in our article on menopause, the drop in estrogen during this period affects the body far more widely than just the menstrual cycle, and vasomotor symptoms are one of the most bothersome, everyday effects of this hormonal shift.

The scale of the problem is large — in studies cited in the context of UK clinical guidelines, vasomotor symptoms affect around 75% of postmenopausal women, and in about a quarter of them the symptoms are severe enough to significantly disrupt sleep, work concentration, and overall quality of life. This is therefore not a marginal inconvenience — for many women, these are daily, repeated episodes that last for months or years.

Hormone replacement therapy (HRT) remains the best-studied and most effective treatment option for these symptoms, but not every woman can or wants to use it — due to contraindications, concerns about cardiovascular and cancer risk (a topic we've covered more broadly regarding the Women's Health Initiative study), or simply a personal preference to avoid hormonal therapy. This is precisely the group of women most likely to turn to herbal alternatives, and black cohosh is by far the most popular choice among them.

What black cohosh is and why it became a popular alternative

Black cohosh (Actaea racemosa, still described in older botanical nomenclature and some literature as Cimicifuga racemosa) is a perennial plant native to North America, whose rhizome has a long history of use in the folk medicine of the continent's indigenous peoples, and since the 19th century also in Western herbal medicine — specifically in the context of "women's" complaints and menopause. This long tradition of use is one of the reasons the supplement gained such wide recognition before modern clinical studies evaluating its effectiveness even appeared.

The mechanism of action isn't fully established

For years it was suggested that black cohosh works through weak estrogen-like activity (binding to estrogen receptors), but newer mechanistic studies have challenged this hypothesis as the main explanation and point instead to a possible effect on the serotonergic system — similar to the mechanism by which some medications used to ease hot flashes work. Neither hypothesis has been unambiguously confirmed as fully explaining the clinical effect, so it's fair to say: the mechanism remains not fully established, rather than definitively described.

This combination — a long tradition of use, over-the-counter availability, and the absence of the hormonal "stigma" associated with HRT — has made black cohosh one of the best-selling supplements in pharmacies and herbal shops dedicated to menopause, often marketed outright as a "natural alternative to hormones."

The network meta-analysis prepared for the NICE guideline

The most credible source of data on black cohosh's effectiveness relative to other treatment options is a network meta-analysis prepared for the UK's National Institute for Health and Care Excellence (NICE) clinical guideline on menopause, published in the journal BJOG in 2017.

Vasomotor symptoms resulting from natural menopause: a systematic review and network meta-analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause

Early-stage evidence

Sarri G, Pedder H, Dias S, Guo Y, Lumsden MA · BJOG · 2017

This Bayesian network meta-analysis included 47 randomized clinical trials and a total of 8,326 participants, comparing 16 different categories of treatment for menopausal vasomotor symptoms (including various forms of hormone replacement therapy, SSRIs/SNRIs, isoflavones, and black cohosh) in women after natural menopause with an intact uterus. Transdermal estrogen-progestogen therapy proved to be the most effective option (69.8% probability of being the most effective treatment; mean ratio MR 0.23; 95% credible interval 0.09-0.57). For isoflavones and black cohosh, the authors report the result qualitatively, without a separate numerical effect size specifically for black cohosh: both options proved more effective than placebo, though not statistically significantly more effective than estrogen-progestogen therapy. SSRIs and SNRIs proved ineffective at relieving vasomotor symptoms and were associated with more frequent treatment discontinuation than placebo.

View study

It's worth paying attention to exactly how the result for black cohosh is phrased: "more effective than placebo, though not statistically significantly more effective than hormone therapy" is a sentence that can be read two ways. On one hand — it suggests black cohosh does in fact work better than nothing (placebo). On the other — the absence of a significant difference versus HRT doesn't automatically mean "equally effective as HRT," only that the difference between them didn't reach the threshold of statistical significance, which, given the smaller number and scale of studies on black cohosh compared to studies on HRT, is a completely different phenomenon from proven equivalence.

Why we don't give a single number for black cohosh here

To be honest: the study abstract doesn't contain an isolated number for black cohosh specifically

The meta-analysis authors report a precise effect size (MR and credible interval) for transdermal estrogen-progestogen therapy — the most effective option evaluated. For black cohosh and isoflavones, the result in the available study summary is described only qualitatively ("more effective than placebo, not significantly less effective than hormone therapy"), without a separately isolated odds ratio, credible interval, or probability ranking specific to black cohosh. Per our editorial rule, we don't invent a number that can't be verified in the source — which is why we describe this result descriptively rather than numerically, and precisely for that reason assign it the cautious "wstepne" (preliminary) evidence level, even though the network meta-analysis method itself is methodologically advanced.

What a network meta-analysis actually means — and where its limits lie

Early-stage evidence

A network meta-analysis combines direct comparisons (studies where two treatments were tested head-to-head) with indirect comparisons (inferred through a common reference point, such as placebo), which makes it possible to simultaneously estimate and compare the effectiveness of many different treatments — in this case as many as 16 categories — even if not all were tested directly against each other in a single study. This is a powerful tool, but its reliability depends on how well "connected" the network of comparisons is: the fewer studies directly tested a given treatment (and there are clearly fewer such studies for black cohosh than for HRT), the lower the certainty of the estimate for that particular branch of the network, even with a methodologically solid overall analysis.

A practical problem: not every "black cohosh" product on the shelf is the same

Even if the clinical effect of black cohosh were unambiguously confirmed, an important problem remains in practice: commercial black cohosh preparations differ in extraction method, standardization to specific active compounds, and dose, and clinical trials in this field have been conducted on different, not necessarily comparable, preparations. A result obtained for one standardized extract in a specific study doesn't necessarily translate directly to the effectiveness of another product on the pharmacy shelf, even if both carry the same plant name on the label.

Reported concerns about liver safety

Some regulatory reviews have noted rare case reports of liver injury temporally linked to the use of black cohosh preparations, which prompted some regulatory agencies to introduce label warnings in certain countries. A causal relationship has not been unambiguously or consistently confirmed across all analyses, and the reports themselves are rare — this is not a reason for panic, but it is a real, documented caution worth knowing about before starting long-term supplementation, especially in the presence of existing liver problems.

Myth versus fact

Myth

Black cohosh is a proven, hormone-free alternative to hormone replacement therapy for relieving hot flashes — just as effective, but without hormonal risk.

Fact

A large network meta-analysis prepared for the NICE guideline did show that black cohosh is more effective than placebo, but with less certainty and less data than for hormone replacement therapy, which remained the most effective option evaluated. The absence of a statistically significant difference versus HRT in this specific analysis is not the same as proof of equivalent effectiveness — and black cohosh preparations also differ in standardization, which makes it difficult to unambiguously generalize study results to every product available on the market.

What's worth doing in practice

Before reaching for black cohosh for menopause symptoms

  • Discuss the decision with a doctor, especially if you're considering it as an alternative to hormone replacement therapy rather than an addition to it
  • Tell your doctor about any existing liver problems or other medications metabolized in the liver before starting long-term supplementation
  • Choose preparations from manufacturers who clearly state the standardization method and the studied dose, rather than products lacking this information on the label
  • Keep realistic expectations about the strength of the effect — available data point to an advantage over placebo, not to effectiveness comparable to hormone replacement therapy
  • Watch for signs of liver problems (including jaundice, dark urine, severe weakness) and stop supplementation and consult a doctor if they appear
  • Don't treat over-the-counter availability as equivalent to no need for consultation — especially with coexisting conditions or other medications being taken

Black cohosh in brief

QuestionShort answer
Does black cohosh work better than placebo?Yes, according to the NICE network meta-analysis (BJOG, 2017) — though without an isolated numerical effect size in the available summary
Is it as effective as hormone replacement therapy?There's no unambiguous proof of this — the absence of a significant difference in this analysis is not the same as confirmed equivalence
What's the mechanism of action?Not fully established — hypotheses include weak estrogen-like activity or an effect on the serotonergic system
Are all black cohosh preparations the same?No — they differ in extraction method, standardization, and dose, which makes generalizing study results difficult
Is it fully safe?Rare cases of liver problems temporally linked to its use have been reported — caution and medical consultation are warranted

Black cohosh and menopause symptoms — key questions

Our editorial recommendation

Black cohosh is not a supplement without any scientific basis — a network meta-analysis prepared for a serious clinical guideline does indeed place it among the options more effective than placebo. The problem lies elsewhere: in the marketing oversimplification that turns "more effective than placebo, with less certainty than HRT" into "a proven, equivalent alternative to hormones." These are two different statements, and the difference between them matters when making a real treatment decision.

Black cohosh deserves a place in the conversation about easing menopause symptoms — but as one option to discuss with a doctor, not as a ready-made answer lifted from the packaging label.

Dr. Anna Kowalczyk, VitMode editorial team

Frequently asked questions

Yes — it's the same plant. Cimicifuga racemosa is the older botanical name, and Actaea racemosa is the currently accepted classification. Both names can be found in the literature and on supplement labels, along with the English term black cohosh, all referring to the same plant.

Available clinical studies don't provide a single, precise answer to this question in general terms — the time to a noticeable effect varied between studies and preparations. Rather than counting on a quick effect, it's worth planning a reasonable trial period with a doctor and evaluating symptoms after it ends.

There's no solid data evaluating the safety and rationale of such a combination, and the decision to combine herbal therapy with hormonal therapy should always go through a medical consultation, rather than being made independently based on a product leaflet.

Because in the available summary of the cited network meta-analysis (Sarri et al., BJOG 2017), the result for black cohosh and isoflavones was given descriptively — as more effective than placebo but not significantly less effective than hormone replacement therapy — without a separately isolated effect size or credible interval specific to black cohosh. We don't want to state a number that can't be verified in the source, so we describe the result qualitatively.

Rare cases of liver problems temporally linked to the use of black cohosh preparations have been reported, prompting some regulatory agencies to add label warnings. An unambiguous causal relationship hasn't been confirmed across all analyses, but that's reason enough to exercise caution and consult a doctor, especially with existing liver disease.

A direct comparison comes from a study where two treatments were tested head-to-head in the same trial. An indirect comparison is inferred through a common reference point — such as placebo — when two treatments were never tested directly against each other. A network meta-analysis combines both types of data, which allows many treatments to be compared at once, but comparisons based mainly on indirect inference are usually subject to greater uncertainty.

Not necessarily — these are different chemical compounds with distinct, not fully explained mechanisms of action. In the cited meta-analysis, however, both were classified similarly in terms of the final outcome (more effective than placebo, not significantly less effective than hormone therapy), which doesn't imply an identical biological mechanism.

Sources

AK

dr Anna Kowalczyk

PhD in Molecular Biology (University of Warsaw), 8 years researching cellular aging

Anna oversees the editorial process and scientific review of every publication in the knowledge base. She previously researched autophagy and mitochondrial biology.

Related articles

Lekarka w białym fartuchu rozmawiająca z pacjentką podczas konsultacji w gabinecie

Hormone Replacement Therapy in Menopause: Who Should Consider It, When, and What's the Real Risk?

The 2002 WHI study triggered a global panic around hormone replacement therapy, and prescriptions dropped by half almost overnight. Two decades of further analysis have painted a much more nuanced picture — one that depends above all on age and timing of initiation. We explain what the data actually show, who has a favorable risk-benefit balance today, and who should exercise particular caution.

13 min

August 22, 2026

Widok z góry na talerz z orzechami, fasolą i nasionami — źródłami błonnika i białka

PCOS and Diet: What to Eat, What to Avoid, to Actually Support Your Hormones

"Eat a low-glycemic-index diet" is the one line PCOS hears most often — rarely explained in terms of what it actually means on your plate. We break down the evidence for low-GI versus low-carb, show what actually moves insulin and androgens, and point out where diet ends and myth begins.

12 min

August 22, 2026

Lekarka wykonująca badanie USG pacjentce w gabinecie medycznym

Endometriosis and Fertility: What the Path to Pregnancy Actually Looks Like

"Endometriosis makes pregnancy impossible" is one of the most repeated, and least accurate, statements women hear after diagnosis. We check what the data on IVF with endometriosis actually show, which interventions genuinely improve the odds of pregnancy, and why hormonal treatment for pain doesn't always help when trying to conceive.

12 min

August 22, 2026

Kobieta szczotkująca swoje długie, ciemne włosy

Minoxidil and Female Pattern Hair Loss — What Does the Cochrane Review Show?

Female pattern hair loss affects millions, yet almost all popular knowledge about minoxidil — ads, forums, product packaging — is written with men in mind. A 2016 Cochrane review, covering more than a dozen trials conducted specifically in women, offers a rarely cited but concrete answer: minoxidil works measurably better than placebo, though the authors themselves rate the underlying evidence as moderate to low quality.

11 min

August 26, 2026

Related knowledge base entries

Comments (2)

  • KW

    Kasia W. 2 weeks ago

    Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.

  • MT

    Marek T. a month ago

    Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.